TY - JOUR
T1 - Protein expression profiling reveals distinctive changes in serum proteins associated with chronic pancreatitis
AU - Hartmann, Daniel
AU - Felix, Klaus
AU - Ehmann, Michael
AU - Schnölzer, Martina
AU - Fiedler, Sabine
AU - Bogumil, Ralf
AU - Büchler, Markus
AU - Friess, Helmut
PY - 2007/11
Y1 - 2007/11
N2 - OBJECTIVE: Testing of serum for protein patterns to monitor progression of suspected to definite chronic pancreatitis (CP). METHODS: Serum samples of CP patients and healthy volunteers were fractionated on anion exchange columns and analyzed by surface-enhanced laser desorption/ionization-time-of-flight mass spectrometry to elucidate CP-related protein alterations and to identify biomarkers for this disease. Potential biomarkers were purified and identified by mass spectrometry. RESULTS: In total, 258 protein peaks were found that discriminated between the 2 groups. Analysis revealed 28 most prominent peaks on immobilized metal affinity capture coupled with Cu and CM10 protein chips, covering the m/z range between 3.3 and 33.3 kd. Performing multivariate pattern analysis, the best pattern model was obtained using fraction 6 on immobilized metal affinity capture coupled with Cu arrays with a sensitivity of 96% and a specificity of 84%. Using a combination of matrix-assisted laser desorption-ionization-time-of-flight mass spectrometry and immunodepletion, we identified 14-m/z peaks. The proteins were found to be significantly decreased in CP serum and were identified as retinol-binding protein, serum amyloid-α, apolipoprotein A-II (Apo A-II), Apo C-I, Apo C-II, Apo C-III, and transthyretin and truncated forms thereof. CONCLUSIONS: Distinct protein profile differences exist between normal and CP serum and reflect the metabolic and inflammatory condition in CP patients. The identified protein panel may eventually serve as a diagnostic marker set for CP.
AB - OBJECTIVE: Testing of serum for protein patterns to monitor progression of suspected to definite chronic pancreatitis (CP). METHODS: Serum samples of CP patients and healthy volunteers were fractionated on anion exchange columns and analyzed by surface-enhanced laser desorption/ionization-time-of-flight mass spectrometry to elucidate CP-related protein alterations and to identify biomarkers for this disease. Potential biomarkers were purified and identified by mass spectrometry. RESULTS: In total, 258 protein peaks were found that discriminated between the 2 groups. Analysis revealed 28 most prominent peaks on immobilized metal affinity capture coupled with Cu and CM10 protein chips, covering the m/z range between 3.3 and 33.3 kd. Performing multivariate pattern analysis, the best pattern model was obtained using fraction 6 on immobilized metal affinity capture coupled with Cu arrays with a sensitivity of 96% and a specificity of 84%. Using a combination of matrix-assisted laser desorption-ionization-time-of-flight mass spectrometry and immunodepletion, we identified 14-m/z peaks. The proteins were found to be significantly decreased in CP serum and were identified as retinol-binding protein, serum amyloid-α, apolipoprotein A-II (Apo A-II), Apo C-I, Apo C-II, Apo C-III, and transthyretin and truncated forms thereof. CONCLUSIONS: Distinct protein profile differences exist between normal and CP serum and reflect the metabolic and inflammatory condition in CP patients. The identified protein panel may eventually serve as a diagnostic marker set for CP.
KW - Biomarker
KW - Chronic pancreatitis
KW - SELDI-TOF-MS
KW - Serum proteomics
UR - http://www.scopus.com/inward/record.url?scp=37349080169&partnerID=8YFLogxK
U2 - 10.1097/mpa.0b013e3180cac723
DO - 10.1097/mpa.0b013e3180cac723
M3 - Article
C2 - 18090239
AN - SCOPUS:37349080169
SN - 0885-3177
VL - 35
SP - 334
EP - 342
JO - Pancreas
JF - Pancreas
IS - 4
ER -